Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

When Garen was diagnosed with lung cancer, biomarker testing helped focus his treatment options, inform his treatment ...

Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail because they don't stay in the body long enough to be effective or because they ...

Lung cancer causes abnormal cells to grow in your lungs. You are at higher risk for lung cancer if you are a current smoker or have smoked regularly in the past. But anyone can get lung cancer. In ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted accelerated approval of tarlatamab (Imdylltra, Amgen) for the treatment of adult patients with advanced small cell lung ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

Medicare covers yearly lung cancer screenings for people with a high risk of developing lung cancer. The eligibility guidelines were expanded in 2022. Original Medicare (parts A and B) and Medicare ...